quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·8d
PRRelease
Tiziana Life Sciences Ltd. logo

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function

TLSA· Tiziana Life Sciences Ltd.
Health Care
Original source

Companies

  • TLSA
    Tiziana Life Sciences Ltd.
    Health Care

Related

  • SEC8d
    SEC Form 6-K filed by Tiziana Life Sciences Ltd.
  • SEC10d
    SEC Form 6-K filed by Tiziana Life Sciences Ltd.
  • PR10d
    Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
  • SEC23d
    SEC Form 6-K filed by Tiziana Life Sciences Ltd.
  • PR23d
    Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
  • INSIDER36d
    SEC Form 3 filed by new insider Cerrone Gabriele M
  • SEC58d
    SEC Form 6-K filed by Tiziana Life Sciences Ltd.
  • PR58d
    Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022